Search filters

List of works by Leena Gandhi

24-Month Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab As First-Line Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer

article by Hossein Borghaei et al published 20 August 2018 in Journal of Thoracic Oncology

A phase 1 study of ABT-806 in subjects with advanced solid tumors

scientific article published on 17 April 2015

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

scientific article published on 01 March 2007

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

scientific article published on 14 November 2018

Abstract A20: MK-3475 monotherapy for previously treated non-small cell lung cancer (NSCLC): Preliminary safety and clinical activity

scientific article published on 15 January 2014

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

scientific article

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

scientific article published on 04 September 2012

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

scientific article

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

scientific article

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

scientific article

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

scientific article published on 2 August 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

scientific article published in September 2017

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

scientific article published on 12 October 2015

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer

scientific article

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

scientific article

Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer

scientific article

Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target

scientific article published on 30 April 2012

Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria

scientific article

Emerging biomarkers for immune checkpoint inhibition in lung cancer

scientific article published on 19 May 2018

Finding a place for ceritinib in the landscape of ALK-positive non-small cell lung cancer

scientific article published in October 2017

High-dose pemetrexed in combination with high-dose crizotinib for the treatment of refractory CNS metastases in ALK-rearranged non-small-cell lung cancer

scientific article

Immunotherapy in patients who have NSCLC without EGFR or ALK mutations

scientific article published on 01 July 2018

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer

scientific article

Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates

scientific article

Management and future directions in non-small cell lung cancer with known activating mutations

scientific article published on January 2014

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

scientific article

PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib

scientific article published on December 2007

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes

scientific article published in Nature

Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer.

scientific article published on 12 July 2018

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

scientific article published on 16 April 2018

Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors

scientific article

Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors

scientific article published on 9 December 2013

Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.

scientific article published on 07 May 2013

Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer

scientific article

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer.

scientific article

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation

scientific article

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.

scientific article

Small cell lung cancer

article

Small cell lung cancer

scientific article published on 01 October 2011

Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis

scientific article published on 31 March 2009

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).

scientific article published on 17 July 2018

The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex

scientific article

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

scientific article

Paulina is supported by:

About Paulina

Help